CoChat

Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care

Open access
Shields, Stephen, Thomas, Roy, Durham, Joy, Moran, Joseph, Clary, Jake, Ciemins, Elizabeth L. · 2024 · Scientific Reports

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Rates of type 2 diabetes (T2D) continue to rise in the United States, with many patients failing to achieve glycemic targets. Primary care providers often serve as the sole clinician managing diabetes. Continuous glucose monitors (CGMs) have shown promise in diabetes management, yet their adoption in primary care settings, especially among patients with T2D not using intensive insulin therapy, remains limited. We sought to evaluate the impact of CGM use on glycemic control in patients with T2D not using insulin and those using basal but not bolus insulin in a primary care setting. CGM use was associated with a significantly greater reduction in HbA1c (-0.62%, p < 0.01) compared with matched controls at 3 months (n = 182). Patients showed improvements in time in range (39.7-61.9%, p < 0.0001), time > 180 mg/dL (60.1-37.9%, p < 0.001), time > 250 mg/dL (27.6-8.5%, p < 0.001), mean estimated glucose value (212 mg/dL to 173 mg/dL, p < 0.001) and glucose management indicator (8.39-7.46%, p < 0.001). CGM use in a primary care setting compared to usual care significantly improved glycemic control in T2D patients not on bolus insulin, irrespective of treatment with non-insulin or basal insulin. This suggests potential for broader CGM integration in primary care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-83548-4

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Difference (gray line) between baseline A1c (blue) and 3-month A1c (orange) for each patient in the control (left) and intervention (right) groups. After 3 months, intervention (CGM) patients had an average unadjusted change in A1c of -1.3% (SD = 1.5%, average baseline A1c = 9.2% (SD = 1.4%), average conclusion A1c = 7.9% (SD = 1.2%)) compared to -0.8% (SD = 1.5%, average baseline A1c = 9.2% (SD = 1.3%), average conclusion A1c = 8.4% (SD = 1.4%)) in the control group (p = 0.011).
Fig. 1 Difference (gray line) between baseline A1c (blue) and 3-month A1c (orange) for each patient in the control (left) and intervention (right) groups. After 3 months, intervention (CGM) patients had an average unadjusted change in A1c of -1.3% (SD = 1.5%, average baseline A1c = 9.2% (SD = 1.4%), average conclusion A1c = 7.9% (SD = 1.2%)) compared to -0.8% (SD = 1.5%, average baseline A1c = 9.2% (SD = 1.3%), average conclusion A1c = 8.4% (SD = 1.4%)) in the control group (p = 0.011).CC BY-NC-ND · PubMed Central
Fig. 2 Change in the proportion of patients with good A1c control (< 7) from baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.01*).
Fig. 2 Change in the proportion of patients with good A1c control (< 7) from baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.01*).CC BY-NC-ND · PubMed Central
Fig. 3 Change in the proportion of patients with good A1c control (< 8) Baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.04*).
Fig. 3 Change in the proportion of patients with good A1c control (< 8) Baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.04*).CC BY-NC-ND · PubMed Central
Fig. 4 Change in the proportion of patients with poor A1c control (> 9) Baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.24*). *Results of difference-in-difference regression analysis controlling for timepoint, diabetes prescription regimen, and chronic kidney disease/diabetic kidney disease with bolded values statistically significant at p < 0.05.
Fig. 4 Change in the proportion of patients with poor A1c control (> 9) Baseline to 3 months in the control (no CGM, green) versus intervention (CGM, red) groups (n = 182, p = 0.24*). *Results of difference-in-difference regression analysis controlling for timepoint, diabetes prescription regimen, and chronic kidney disease/diabetic kidney disease with bolded values statistically significant at p < 0.05.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 31

Metadata

Authors
Shields, S., Thomas, R., Durham, J., Moran, J., Clary, J., & Ciemins, E. L.
Affiliations
  • American Medical Group Association (US)
  • Dexcom (United States) (US)
  • Piedmont HealthCare (US)
Corresponding author
Shields, Stephen
Venue
Scientific Reports
Published
2024-12-30
Volume
14
Issue
1
Pages
31990-31990
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4405898671
Cited by
28
References
24
Citations by year
2026: 18 · 2025: 10
FWCI
9.22
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Dexcom
  • American Medical Group Association
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
continuous glucose monitoring, type 2 diabetes, glycemic control, HbA1c, basal insulin, primary care, time in range, glucose management indicator, hyperglycemia, device adoption
MeSH terms
Glycemic Control, Continuous Glucose Monitoring, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Primary Health Care, Blood Glucose Self-Monitoring

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care. https://app.cochat.ai/papers/10.1038/s41598-024-83548-4
The paper
Shields, S., Thomas, R., Durham, J., Moran, J., Clary, J., & Ciemins, E. L. (2024). Continuous glucose monitoring among adults with type 2 diabetes receiving noninsulin or basal insulin therapy in primary care. Scientific Reports. https://doi.org/10.1038/s41598-024-83548-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.